Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells.

These findings suggested that acacetin augments the cytotoxicity of doxorubicin at lower concentrations in lung cancer cells. Their combination leads to more retention of doxorubicin in the cells by modulating drug trasporter and thus enhances its therapeutic potential.